Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $40.99 and traded as high as $45.96. Simulations Plus shares last traded at $45.65, with a volume of 141,941 shares trading hands.
Analyst Ratings Changes
Separately, Craig Hallum upped their price target on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a research report on Thursday, January 4th.
Read Our Latest Stock Report on SLP
Simulations Plus Stock Down 2.0 %
Simulations Plus (NASDAQ:SLP – Get Free Report) last posted its earnings results on Wednesday, April 3rd. The technology company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. The company had revenue of $18.31 million during the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a net margin of 16.22% and a return on equity of 7.95%. Simulations Plus’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share. On average, equities research analysts forecast that Simulations Plus, Inc. will post 0.67 EPS for the current year.
Simulations Plus Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, May 6th. Investors of record on Monday, April 29th will be paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.54%. The ex-dividend date of this dividend is Friday, April 26th. Simulations Plus’s payout ratio is currently 45.28%.
Insider Buying and Selling
In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $39.94, for a total value of $798,800.00. Following the completion of the transaction, the director now directly owns 3,600,195 shares of the company’s stock, valued at $143,791,788.30. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Simulations Plus news, Director Walter S. Woltosz sold 18,945 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $38.02, for a total transaction of $720,288.90. Following the completion of the transaction, the director now owns 3,641,250 shares of the company’s stock, valued at $138,440,325. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $39.94, for a total transaction of $798,800.00. Following the transaction, the director now directly owns 3,600,195 shares of the company’s stock, valued at approximately $143,791,788.30. The disclosure for this sale can be found here. 20.90% of the stock is owned by insiders.
Hedge Funds Weigh In On Simulations Plus
Institutional investors and hedge funds have recently made changes to their positions in the business. Conestoga Capital Advisors LLC increased its position in shares of Simulations Plus by 12.5% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,259,176 shares of the technology company’s stock valued at $101,098,000 after acquiring an additional 251,299 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Simulations Plus by 0.4% during the third quarter. Vanguard Group Inc. now owns 1,118,878 shares of the technology company’s stock valued at $46,657,000 after acquiring an additional 5,009 shares in the last quarter. Ranger Investment Management L.P. increased its position in shares of Simulations Plus by 1.4% during the fourth quarter. Ranger Investment Management L.P. now owns 931,132 shares of the technology company’s stock valued at $41,668,000 after acquiring an additional 12,505 shares in the last quarter. Invesco Ltd. increased its position in shares of Simulations Plus by 1.1% during the third quarter. Invesco Ltd. now owns 469,958 shares of the technology company’s stock valued at $19,597,000 after acquiring an additional 5,107 shares in the last quarter. Finally, Wasatch Advisors LP increased its position in shares of Simulations Plus by 36.5% during the first quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock valued at $15,707,000 after acquiring an additional 102,135 shares in the last quarter. Institutional investors own 78.08% of the company’s stock.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles
- Five stocks we like better than Simulations Plus
- Technology Stocks Explained: Here’s What to Know About Tech
- MarketBeat Week in Review – 4/22 – 4/26
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.